3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Interventions
pembrolizumab
1
fludarabine
1
Everolimus
1
Cyclophosphamide
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thymus Neoplasms
×
amrubicin
×
90 days
×
Clear all
No trials found.